'Sensitivity gene' predicts whether anxious children will benefit from CBT

October 25, 2011

(Medical Xpress) -- Research funded by the Medical Research Council (MRC) has shown that a genetic marker, called Serotonin Transporter Promoter Polymorphism (5HTPP), can be used to predict whether a child suffering from anxiety disorder will benefit from cognitive behaviour therapy (CBT). This is the first time that genetic analysis has been used to assess whether a psychological treatment like CBT will work for children.

The research team, led by Dr Thalia Eley at the Institute of Psychiatry at King’s College London, collected DNA from 359 diagnosed with disorder, which affects around one in twenty children in the UK. Those found to have a shorter version of the 5HTPP were 20 per cent more likely to respond to CBT and to be free of their anxiety six months after the end of their treatment.

Two forms of the 5HTTP gene commonly exist within the human population; a short form and a long form. The short form has previously been shown to predict which individuals are likely to be prone to depression when under stress. More recently it has been proposed that the short form influences how individuals respond to their environment more generally, be it positive or negative. In this study children with the short form of the gene were more responsive to the positive environment of CBT, and were more likely to get better.

Dr Thalia Eley from the Institute of Psychiatry at King’s College London says:

“Childhood anxiety is beginning to be recognised as a serious health problem. Many children with severe anxiety end up missing school and losing out on normal opportunities, not just in school but socially. CBT has been shown to help individuals think about the world around them and to experience their environment in a more health, positive way and hopefully stem the impact of anxiety before it gets worse in adulthood.

“Our study showed that having a short form of the gene, which can contribute to a child feeling more negative when things are stressful, may have a positive flipside, in that they are more responsive to the positive messages taught in CBT.”

Professor Chris Kennard, chair of the MRC Neurosciences and Mental Health Board that funded the research, says:

“Studies exploring whether might be helpful in deciding whether a drug treatment will or will not work have exploded over the last ten years. What is fascinating about this study is that this is the first time that a gene has been used to determine whether a is likely to have a therapeutic effect. The Medical Research Council is committed to funding research that will lead to better, more effective treatments for patients and hopefully this research will lead to a more tailored approach for treating anxiety.”

More information: Original Research paper: Therapygenetics: predicting response to psychological therapy from a genetic marker is published in Molecular Psychiatry

Related Stories

Recommended for you

Oxytocin enhances spirituality, new study says

September 21, 2016

Oxytocin has been dubbed the "love hormone" for its role promoting social bonding, altruism and more. Now new research from Duke University suggests the hormone may also support spirituality.

Study reveals a biological link between stress and obesity

September 21, 2016

Metabolic and anxiety-related disorders both pose a significant healthcare burden, and are in the spotlight of contemporary research and therapeutic efforts. Although intuitively we assume that these two phenomena overlap, ...

Men with anxiety are more likely to die of cancer, study says

September 20, 2016

Men over 40 who are plagued with the omnipresent of generalized anxiety disorder are more than twice as likely to die of cancer than are men who do not have the mental affliction, new research finds. But for women who suffer ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.